1. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours;Bodei;Eur J Nucl Med Mol Imaging,2013
2. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: alpha therapy with 223Ra-dichloride;Pandit-Taskar;J Nucl Med,2014
3. International Commission on Radiological Protection: The 2007 recommendations of the ICRP. ICRP Publication 103. Ann. ICRP 2007; 37(2–4).
4. International commission on radiation units and measurements. Quantities and units in radiation protection dosimetry 1993 ICRU Report 51.
5. United States Nuclear Regulatory Commission, NRC, NRC Regulations Title 10, Code of Federal Regulations, PART 20—Standards for protection against radiation, § 20.1208 Dose equivalent to an embryo/fetus, www.nrc.gov/reading-rm/doc-collections/cfr/part020/part020-1208.html, accessed 19.01.17.